Literature DB >> 12849007

Insulin autoimmunity: prediction/precipitation/prevention type 1A diabetes.

George S Eisenbarth1, Hiroaki Moriyama, David T Robles, Edwin Liu, Liping Yu, Sunanda Babu, Maria J Redondo, Maria Redondo, Peter Gottlieb, Dale Wegmann, Marian Rewers.   

Abstract

Type 1 diabetes of both the NOD mouse and man is associated with autoimmunity directed against insulin which is the only beta cell specific autoantigen identified to date. One can use autoantibodies to insulin to predict diabetes, use insulin peptides to create insulin autoantibodies, insulitis and diabetes, and use insulin or its peptides in animal models to prevent diabetes. An expanding set of resources are now available for the development and testing in man of therapies to prevent type 1 diabetes, and a number of trials utilizing insulin peptides are now underway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12849007     DOI: 10.1016/s1568-9972(02)00035-6

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  16 in total

1.  Genetic associations of FCRL3 polymorphisms with the susceptibility of Graves ophthalmopathy in a Chinese population.

Authors:  Shanshan Wu; Ting Cai; Feng Chen; Xuefei He; Zhihua Cui
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes.

Authors:  Stuart E Turvey; Eric Swart; Maria C Denis; Umar Mahmood; Christophe Benoist; Ralph Weissleder; Diane Mathis
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

3.  NFATc2 (NFAT1) assists BCR-mediated anergy in anti-insulin B cells.

Authors:  Rachel H Bonami; William T Wolfle; James W Thomas; Peggy L Kendall
Journal:  Mol Immunol       Date:  2014-02-06       Impact factor: 4.407

4.  How C-terminal additions to insulin B-chain fragments create superagonists for T cells in mouse and human type 1 diabetes.

Authors:  Yang Wang; Tomasz Sosinowski; Andrey Novikov; Frances Crawford; Janice White; Niyun Jin; Zikou Liu; Jinhao Zou; David Neau; Howard W Davidson; Maki Nakayama; William W Kwok; Laurent Gapin; Philippa Marrack; John W Kappler; Shaodong Dai
Journal:  Sci Immunol       Date:  2019-04-05

5.  Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes.

Authors:  Angela Lombardi; Erlinda Concepcion; Hanxi Hou; Hanane Arib; Mihaly Mezei; Roman Osman; Yaron Tomer
Journal:  J Autoimmun       Date:  2020-09-17       Impact factor: 7.094

6.  Deficiency in B7-H1 (PD-L1)/PD-1 coinhibition triggers pancreatic beta-cell destruction by insulin-specific, murine CD8 T-cells.

Authors:  Tarvo Rajasalu; Helen Brosi; Cornelia Schuster; Andreas Spyrantis; Bernhard Otto Boehm; Lieping Chen; Jörg Reimann; Reinhold Schirmbeck
Journal:  Diabetes       Date:  2010-05-18       Impact factor: 9.461

7.  Mucosal tolerance to prevent type 1 diabetes: can the outcome be improved in humans?

Authors:  Arno Hanninen; Leonard C Harrison
Journal:  Rev Diabet Stud       Date:  2004-11-10

Review 8.  Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE.

Authors:  Kevin D Deane; Hani El-Gabalawy
Journal:  Nat Rev Rheumatol       Date:  2014-02-11       Impact factor: 20.543

9.  Imaging inflammation of the pancreatic islets in type 1 diabetes.

Authors:  Maria C Denis; Umar Mahmood; Christophe Benoist; Diane Mathis; Ralph Weissleder
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-10       Impact factor: 11.205

Review 10.  Central and peripheral autoantigen presentation in immune tolerance.

Authors:  Alberto Pugliese
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.